OMNIMMUNE HOLDINGS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0001 USD | +49.25% |
|
-.--% | -.--% |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
| Sales 2008 | - | Sales 2009 | - | Capitalization | 1.43M 1.94M |
|---|---|---|---|---|---|
| Net income 2008 | -5M -6.81M | Net income 2009 | -1M -1.36M | EV / Sales 2008 | - |
| Net Debt 2008 | 2.3M 3.14M | Net Debt 2009 | 2.58M 3.51M | EV / Sales 2009 | - |
| P/E ratio 2008 |
-0.55
x | P/E ratio 2009 |
-0.8
x | Employees | 2 |
| Yield 2008 * |
-
| Yield 2009 |
-
| Free-Float | 42.13% |
More Fundamentals
* Assessed data
| 1 day | +49.25% |
1 year
0.00
0.00
3 years
0.000.02
5 years
0.000.05
10 years
0.000.05
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 71 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 71 | - |
Omnimmune Holdings, Inc. (Omnimmune) is a development-stage biotechnology company integrating complementary cancer therapeutic, diagnostic and prognostic technologies. The Company is the holding company of Omnimmune Corp. Omnimmune has acquired licensed rights to diagnostic and platform monoclonal antibody technologies. Omnimmuneâs hCGÃ and related technologies, which are protected through an expanding intellectual property portfolio, have been developed at institutions including Columbia University of New York, New York (Columbia), The Allegheny-Singer Research Institute of the West Penn Allegheny Health System, Pittsburgh, Pennsylvania (Allegheny) and The Institute Gustave Roussy, Paris, France (IGR).
| 1st Jan change | Capi. | |
|---|---|---|
| -.--% | 980 | |
| +33.37% | 50.85B | |
| +1.55% | 42.82B | |
| +50.18% | 42.03B | |
| -4.22% | 29.55B | |
| +11.57% | 26.11B | |
| -21.00% | 19.13B | |
| +7.36% | 13.05B | |
| +28.30% | 12.16B | |
| +23.80% | 12.08B |
- Stock Market
- Equities
- OMMH Stock
